Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bionovate Technologies Corp (BIIO)
:BIIO
BIIO Stock Chart & Stats
Day’s RangeN/A
52-Week Range― - ―
Previous CloseN/A
Volume1.01K
Average Volume (3M)83.00
Market Cap
$775.00
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-12.19
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding7,753,598
10 Day Avg. Volume171
30 Day Avg. Volume83
Standard Deviation25.12
R-Squared0.00430
Alpha6.31
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
BIIO FAQ
What was Bionovate Technologies Corp’s price range in the past 12 months?
Currently, no data Available
What is Bionovate Technologies Corp’s market cap?
Bionovate Technologies Corp’s market cap is $775.00.
When is Bionovate Technologies Corp’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Bionovate Technologies Corp’s earnings last quarter?
Currently, no data Available
Is Bionovate Technologies Corp overvalued?
According to Wall Street analysts Bionovate Technologies Corp’s price is currently Overvalued.
Does Bionovate Technologies Corp pay dividends?
Bionovate Technologies Corp does not currently pay dividends.
What is Bionovate Technologies Corp’s EPS estimate?
Bionovate Technologies Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bionovate Technologies Corp have?
Bionovate Technologies Corp has 7,753,598 shares outstanding.
What happened to Bionovate Technologies Corp’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Bionovate Technologies Corp?
Currently, no hedge funds are holding shares in BIIO
---
Company Description
Bionovate Technologies Corp
Bionovate Technologies Corp. engages in the acquisition and development of technologies based on protected and wholly-owned internet protocol in the medical devices sector. The company was founded on October 24, 2012 and is headquartered in Tel Aviv, Israel.
---
BioLife Solutions
―
CryoPort
―
Applied DNA Sciences
―
Helius Medical Technologies
―
Verb Technology Company
―
---